Transgene Biotek Financials

BSE: 526139

₹2.72

₹-0.05 (-1.81%)

As on 04-Sep-2026IST

Market cap

₹21 Cr

Revenue (TTM)

₹0 Cr

P/E Ratio

--

P/B Ratio

2.6

Div. Yield

0 %

Income Statement (₹ Cr)	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Operating Revenue	0.22	0.26	0.23	0.06	0.09	0.17
Total Income	0.37	1.04	0.42	0.23	0.30	0.44
Total Expenditure	0.69	1.38	0.84	0.67	0.55	0.69
EBITDA	-0.46	-1.12	-0.61	-0.61	-0.46	-0.52
Depreciation	0.19	0.09	0.09	4.95	9.92	9.91
EBIT	-0.65	-1.21	-0.70	-5.56	-10.39	-10.43
Interest	1.11	0.24	0.14	0.62	0.23	0.27
Other Income	0.15	0.78	0.18	0.18	0.21	0.27
Exceptional Items	--	--	--	--	--	--
Profit before Tax	-1.61	-0.68	-0.66	-6.01	-10.40	-10.43
Provision for Tax	--	--	--	--	--	--
Profit after Tax	-1.61	-0.68	-0.66	-6.01	-10.40	-10.43
Minority Interest	--	--	--	--	--	--
Share of Associate	--	--	--	--	--	--
Consolidated Profit	-1.61	-0.68	-0.66	-6.01	-10.40	-10.43

Liabilities (₹ Cr)	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Shareholder's Funds	9.21	10.03	10.71	11.37	17.38	22.24
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	121.66	121.32	120.48	120.52	120.52	120.47
Current Liabilities	12.88	12.74	11.14	10.47	9.21	14.18
Total Liabilities	143.75	144.09	142.33	142.36	147.10	156.88

Assets (₹ Cr)	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Non-Current Assets	142.73	142.83	141.22	141.31	146.40	156.23
Current Assets	1.02	1.26	1.11	1.04	0.70	0.65
Total Assets	143.75	144.09	142.33	142.36	147.10	156.88
Total Debt*	--	14.52	14.00	13.11	12.01	11.33
Net Current Assets	-11.86	-11.47	-10.03	-9.42	-8.51	-13.53
Contingent Liabilities	--	2.58	0.55	0.99	1.29	1.29

Cashflow (₹ Cr)	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Cash From Operating Activities	--	1.20	0.00	0.00	0.10	0.01
Cash Flow from Investing Activities	--	-1.70	--	-0.01	-0.10	-0.03
Cash from Financing Activities	--	0.78	--	--	--	0.00
Net Cash Inflow / Outflow	--	0.28	0.00	-0.01	0.00	-0.01

Financials Ratios	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Adjusted EPS (₹)	-0.21	-0.09	-0.09	-0.79	-1.37	-1.38
Cash EPS (₹)	-0.21	-0.08	-0.07	-0.14	-0.06	-0.07
Adjusted Book Value (₹)	1.05	1.32	1.41	1.50	2.29	2.94
Dividend per Share (₹)	--	--	--	--	--	--
Cash Flow per Share (₹)	--	0.16	0.00	--	0.01	0.00
Free Cash Flow per Share (₹)	--	-0.07	0.01	0.00	0.01	-0.01

Profitability Ratios	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
ROCE (%)	--	-1.75	-2.10	-19.99	-32.32	-26.55
ROE (%)	-16.73	-6.52	-5.94	-41.80	-52.51	-38.00
ROA (%)	-1.13	-0.47	-0.46	-4.15	-6.84	-6.45
EBIT Margin (%)	-293.27	-465.94	-297.40	-10,091.47	-11,979.29	-6,151.86
Net Margin (%)	-431.37	-64.75	-156.97	-2,606.77	-3,476.29	-2,390.82
Cash Profit Margin (%)	0.00	-223.59	-239.76	-1,921.05	-550.95	-310.61

Growth Ratios	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Revenue Growth (%)	-14.89	10.98	326.32	-36.44	-48.87	4,642.12
EBIT Growth (%)	32.58	-73.88	87.44	46.46	0.43	3.06
Net Profit Growth (%)	-22.92	-3.14	89.09	42.24	0.31	4.81
EPS Growth (%)	-22.87	-3.12	89.09	42.23	0.32	4.81
Book Value Growth (%)	--	-6.38	-5.77	-34.58	-21.86	-31.94

Valuation Ratios	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Price / Earnings	-12.81	--	--	--	--	--
Price / Book Value	2.58	2.53	5.76	1.66	1.57	1.56
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-118.38	-117.21	-178.64	-73.53	-158.30	-180.05
Close Price (₹)	3.03	3.35	8.14	2.49	3.61	4.58
High Price (₹)	5.26	10.84	12.46	4.41	5.93	6.85
Low Price (₹)	1.83	3.32	2.28	2.28	3.02	2.85
Market Cap (₹ Cr)	20.61	25.38	61.68	18.87	27.35	34.70

Solvency Ratios	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Debt to Equity	0.70	1.45	1.31	1.15	0.69	0.51
Short term debt to equity ratio	--	0.84	0.83	0.72	0.42	0.31
Current Ratio	0.08	0.10	0.10	0.10	0.08	0.05
Quick Ratio	0.08	0.10	0.10	0.10	0.07	0.04
Interest Coverage	-0.46	-1.76	-3.70	-8.64	-44.40	-37.49

Operating Efficiency Ratios	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Debtors to sales (%)	3.59	3.22	3.58	15.25	9.74	4.98
Asset Turnover	0.00	0.00	0.00	0.00	0.00	0.00
Receivable days	--	11.76	13.05	55.80	35.56	18.18
Inventory Days	--	47.53	52.60	425.35	242.36	63.44
Payable days	--	--	--	1,187.70	-1,746.92	1,857.70
Cash Conversion Cycle	--	--	65.65	-706.55	2,024.85	-1,776.08

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.